Position in SCYX
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$4
-$7 QoQ
Shares Held
1
-50.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 39 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SCYX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bogart Wealth, LLC holds $149,547 across 19 Drug Manufacturers - Specialty & Generic names. SCYX ranks #18 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
2,547 | $88,304 | |
| 2 | ZTS |
Zoetis Inc.
|
351 | $25,222 | |
| 3 | HLN |
Haleon plc
|
2,235 | $20,852 | |
| 4 | TRLV |
Trulieve Cannabis Corp.
|
500 | $4,915 | |
| 5 | VTRS |
Viatris Inc
|
177 | $2,810 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
14 | $2,359 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
3 | $1,625 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
37 | $910 |
All Filings in SCYX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4 | 1 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $11 | 12 | Shares | Sole | 2026-04-28 | |
| No filing history on record for this holder in this stock. | ||||||